Effect of simvastatin on castration-resistant prostate cancer cells
about
Raman and coherent anti-Stokes Raman scattering microscopy studies of changes in lipid content and composition in hormone-treated breast and prostate cancer cellsOral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts.Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR.Low-dose statin treatment increases prostate cancer aggressiveness.Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1.
P2860
Effect of simvastatin on castration-resistant prostate cancer cells
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Effect of simvastatin on castration-resistant prostate cancer cells
@en
type
label
Effect of simvastatin on castration-resistant prostate cancer cells
@en
prefLabel
Effect of simvastatin on castration-resistant prostate cancer cells
@en
P2093
P2860
P356
P1476
Effect of simvastatin on castration-resistant prostate cancer cells
@en
P2093
Jenny Hanbi Kim
Kishor M Wasan
Michael E Cox
P2860
P2888
P356
10.1186/1476-511X-13-56
P577
2014-03-26T00:00:00Z
P6179
1038676238